Charles F Wagner Jr Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Charles F Wagner Jr is EVP & Chief Financial Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 51,671 shares of VRTX, which is worth approximately $26 Million. The most recent transaction as insider was on Feb 10, 2023, when has been sold 2,707 shares (Common Stock) at a price of $294.33 per share, resulting in proceeds of $796,751. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.7K

17.07% 3M change

3.57% 12M change

Total Value Held $26 Million

CHARLES F WAGNER Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2023	SELL Payment of exercise price or tax liability	$796,751 $294.33 p/Share	2,707 Reduced 3.71%	70,183 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	30,026 Added 29.18%	72,890 Common Stock
May 02 2022	SELL Open market or private sale	$89,046 $259.61 p/Share	343 Reduced 0.8%	42,730 Common Stock
Apr 29 2022	SELL Payment of exercise price or tax liability	$151,065 $276.17 p/Share	547 Reduced 1.25%	43,073 Common Stock
Apr 01 2022	SELL Open market or private sale	$683,094 $264.56 p/Share	2,582 Reduced 5.59%	43,620 Common Stock
Mar 17 2022	SELL Open market or private sale	$794,621 $250.59 p/Share	3,171 Reduced 6.42%	46,202 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$498,786 $227.86 p/Share	2,189 Reduced 4.25%	49,373 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$799,602 $232.51 p/Share	3,439 Reduced 6.25%	51,562 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$578,659 $237.74 p/Share	2,434 Reduced 4.24%	55,001 Common Stock
Feb 02 2022	SELL Open market or private sale	$736,206 $250.07 p/Share	2,944 Reduced 4.88%	57,435 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	25,588 Added 29.76%	60,379 Common Stock
Apr 30 2021	SELL Payment of exercise price or tax liability	$118,814 $217.21 p/Share	547 Reduced 1.55%	34,679 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$119,011 $217.57 p/Share	547 Reduced 1.53%	35,226 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$506,488 $214.16 p/Share	2,365 Reduced 6.2%	35,773 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	21,951 Added 36.53%	38,138 Common Stock

Also insider at

TJX

TJX COMPANIES INC Consumer Cyclical

CFW